Atlas Trials

Pivotal Bioequivalence Study of Exemestane 25 mg Tablets Under Fasting Conditions in Healthy Subjects

Clinical trial NCT01760980 · WITHDRAWN

Trial details

NCT number
NCT01760980
Sponsor
Actavis Inc.
Status
WITHDRAWN
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy
Start date
2012-11-01
Primary completion
2014-12-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.